dobutamine

Generic: dobutamine

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name dobutamine
Generic Name dobutamine
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

dobutamine hydrochloride 200 mg/100mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1330
Product ID 51662-1330_100c9203-3714-02bc-e063-6294a90afb2f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020201
Listing Expiration 2026-12-31
Marketing Start 2019-04-07

Pharmacologic Class

Classes
adrenergic beta-agonists [moa] beta-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621330
Hyphenated Format 51662-1330

Supplemental Identifiers

RxCUI
309986
UNII
0WR771DJXV

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dobutamine (source: ndc)
Generic Name dobutamine (source: ndc)
Application Number NDA020201 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 200 mg/100mL
source: ndc
Packaging
  • 250 mL in 1 BAG (51662-1330-1)
source: ndc

Packages (1)

51662-1330-1 250 mL in 1 BAG (51662-1330-1)

Ingredients (1)

dobutamine hydrochloride (200 mg/100mL)

Linked Drug Pages (1)

DOBUTAMINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "100c9203-3714-02bc-e063-6294a90afb2f", "openfda": {"unii": ["0WR771DJXV"], "rxcui": ["309986"], "spl_set_id": ["85fb5ba6-3597-e09f-e053-2a91aa0aded5"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 BAG (51662-1330-1)", "package_ndc": "51662-1330-1", "marketing_start_date": "20190407"}], "brand_name": "DOBUTAMINE", "product_id": "51662-1330_100c9203-3714-02bc-e063-6294a90afb2f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic beta-Agonists [MoA]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1330", "generic_name": "DOBUTAMINE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DOBUTAMINE", "active_ingredients": [{"name": "DOBUTAMINE HYDROCHLORIDE", "strength": "200 mg/100mL"}], "application_number": "NDA020201", "marketing_category": "NDA", "marketing_start_date": "20190407", "listing_expiration_date": "20261231"}